PRESS RELEASE
News
-
-
PRESS RELEASE
Exosens secures €140 million in EIB financing to foster innovation in Europe’s defense and security industry
Exosens secures €140 million EIB financing to foster innovation in Europe's defense and security industry, supporting technology development and industrial footprint in line with EIB strategic priorities -
PRESS RELEASE
Transgene to Present Preclinical Data Demonstrating Robust Protection Against Mpox with its Novel Scalable Cell Line–Derived MVA Vaccine Candidate (TG MVA(TM)) at WCID 2026
Transgene to present positive preclinical data on TG-MVATM vaccine candidate against Mpox at WCID 2026. The cell-line based vaccine offers robust protection with scalable manufacturing -
PRESS RELEASE
Transgene présente des données précliniques de son vaccin innovant contre le mpox produit sur lignée cellulaire, TG-MVA
Transgene présente des données précliniques prometteuses de son vaccin innovant contre le mpox, basé sur MVA et produit sur lignée cellulaire, au World Congress on Infectious Diseases. Potentiel d'approvisionnement global en vaccins -
-
-
-
-
-
PRESS RELEASE
DocMorris announces accelerated implementation of its “AI-First” strategy; positive cost savings of at least CHF 15 million per year
DocMorris accelerates 'AI-First' strategy, targeting CHF 15m annual cost savings. Automation & efficiency gains lead to FTE reductions & enhanced customer-centric focus
